Quest Diagnostics (DGX) Operating Leases (2019 - 2026)
Quest Diagnostics' Operating Leases history spans 8 years, with the latest figure at $574.0 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 6.69% to $574.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $574.0 million, a 6.69% increase, with the full-year FY2025 number at $537.0 million, down 25.93% from a year prior.
- Operating Leases hit $574.0 million in Q1 2026 for Quest Diagnostics, up from $537.0 million in the prior quarter.
- Over the last five years, Operating Leases for DGX hit a ceiling of $725.0 million in Q4 2024 and a floor of $489.0 million in Q4 2022.
- Historically, Operating Leases has averaged $529.8 million across 5 years, with a median of $508.0 million in 2023.
- Biggest five-year swings in Operating Leases: decreased 27.98% in 2022 and later skyrocketed 44.14% in 2024.
- Tracing DGX's Operating Leases over 5 years: stood at $489.0 million in 2022, then grew by 2.86% to $503.0 million in 2023, then surged by 44.14% to $725.0 million in 2024, then decreased by 25.93% to $537.0 million in 2025, then increased by 6.89% to $574.0 million in 2026.
- Business Quant data shows Operating Leases for DGX at $574.0 million in Q1 2026, $537.0 million in Q4 2025, and $534.0 million in Q3 2025.